• Policy
• There were more than 20 doses of Dapagliflozin 5mg
• by Lee, Tak-Sun Nov 2, 2023 05:35am

• Company
• Public petition filed for the reimb of Verzenio
• by Eo, Yun-Ho Nov 2, 2023 05:35am

• Policy
• Complete deletion of Ranitidine from the list of benefits
• by Lee, Tak-Sun Nov 1, 2023 05:40am

• Company
• Daewoong-Merck pursues full-cycle AI-based new drug dev
• by Lee, Seok-Jun Nov 1, 2023 05:40am

• Policy
• Hanmi recieves 1st approval for aspirin+rabeprazole combo
• by Lee, Hye-Kyung Nov 1, 2023 05:40am

• Company
• 5th JAK inhibitor released…heats up competition
• by Kim, Jin-Gu Nov 1, 2023 05:40am

• Company
• Gilead aims for reimbursement of COVID-19 tx Veklury
• by Eo, Yun-Ho Nov 1, 2023 05:40am

• Policy
• HIRA ‘Will advance CDDC result disclosure within the year'
• by Lee, Jeong-Hwan Oct 31, 2023 05:35am

• Policy
• Roche Lunsumio, domestic approval imminent
• by Lee, Hye-Kyung Oct 31, 2023 05:35am

• Company
• Global biosimilar market worth KRW 3.9 tril…Pfizer vs Amgen
• by Kim, Jin-Gu Oct 31, 2023 05:35am